CD4 and neoplasm: We have shown that MMP-2 can directly modulate innate and adaptive immune responses toward melanoma by not only being recognized by specific CD4+ and CD8+ tumor-infiltrating T cells, but also by modulating DC function to polarize TH2 responses.